Search research articles
Contact Us
Filters
Showing results (11-20 of 44) with videos related to
Page
of 5
Sort By:
Jac-Antimicrobial Resistance
|
May 24, 2023
Treatment decisions in VRE bacteraemia: a survey of infectious diseases pharmacists
Bryan P White, Katie E Barber, Daniel B Chastain
Journal of Pharmacy Practice
|
August 16, 2021
Variation Among Infectious Diseases Pharmacists for the Treatment of <i>Staphylococcus aureus</i> Bacteremia
Bryan P White, Katie E Barber, Daniel B Chastain
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians
|
November 9, 2021
Review of Ceftazidime-Avibactam, Meropenem-Vaborbactam, and Imipenem/Cilastatin-Relebactam to Target <i>Klebsiella pneumoniae</i> Carbapenemase-Producing Enterobacterales
Dillon A Hayden, Bryan P White, Kiya K Bennett
Infectious Diseases (London, England)
|
January 22, 2019
Adding double carbapenem therapy to the armamentarium against carbapenem-resistant Enterobacteriaceae bloodstream infections
Bryan P White, Smit Patel, Janice Tsui, et al.
Open Forum Infectious Diseases
|
October 18, 2023
Impact of Fluoroquinolone Susceptibility Suppression on Discharge Prescribing for Acute Uncomplicated Cystitis
Dillon A Hayden, Bryan P White, Stephen Neely, et al.
Pharmacotherapy
|
October 24, 2017
What Is Old Is New Again: Delafloxacin, a Modern Fluoroquinolone
Jonathan C Cho, Matthew P Crotty, Bryan P White, et al.
The Annals of Pharmacotherapy
|
December 15, 2017
Is It Time to Rethink the Notion of Carbapenem-Sparing Therapy Against Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Bloodstream Infections? A Critical Review
Daniel B Chastain, Bryan P White, David A Cretella, et al.
Jac-Antimicrobial Resistance
|
March 27, 2026
In a bind: a quality improvement project for reducing fluoroquinolones drug-drug interactions with multivalent cations
Emily A Siegrist, Steven J Pan, Maria Alkozah, et al.
Open Forum Infectious Diseases
|
April 17, 2025
Rates of Acute Kidney Injury Utilizing Area Under the Concentration-Time Curve Versus Trough-Based Vancomycin Dosing Strategies in Patients With Obesity
Corey M Guidry, Emily A Siegrist, Stephen B Neely, et al.
Southern Medical Journal
|
February 3, 2018
Risk Factors for Failure in Complicated Intraabdominal Infections
Bryan P White, Jamie L Wagner, Katie E Barber, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 44) with videos related to
Sort By:
Page
of 5
Jac-Antimicrobial Resistance
|
May 24, 2023
Treatment decisions in VRE bacteraemia: a survey of infectious diseases pharmacists
Bryan P White, Katie E Barber, Daniel B Chastain
Journal of Pharmacy Practice
|
August 16, 2021
Variation Among Infectious Diseases Pharmacists for the Treatment of <i>Staphylococcus aureus</i> Bacteremia
Bryan P White, Katie E Barber, Daniel B Chastain
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians
|
November 9, 2021
Review of Ceftazidime-Avibactam, Meropenem-Vaborbactam, and Imipenem/Cilastatin-Relebactam to Target <i>Klebsiella pneumoniae</i> Carbapenemase-Producing Enterobacterales
Dillon A Hayden, Bryan P White, Kiya K Bennett
Infectious Diseases (London, England)
|
January 22, 2019
Adding double carbapenem therapy to the armamentarium against carbapenem-resistant Enterobacteriaceae bloodstream infections
Bryan P White, Smit Patel, Janice Tsui, et al.
Open Forum Infectious Diseases
|
October 18, 2023
Impact of Fluoroquinolone Susceptibility Suppression on Discharge Prescribing for Acute Uncomplicated Cystitis
Dillon A Hayden, Bryan P White, Stephen Neely, et al.
Pharmacotherapy
|
October 24, 2017
What Is Old Is New Again: Delafloxacin, a Modern Fluoroquinolone
Jonathan C Cho, Matthew P Crotty, Bryan P White, et al.
The Annals of Pharmacotherapy
|
December 15, 2017
Is It Time to Rethink the Notion of Carbapenem-Sparing Therapy Against Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Bloodstream Infections? A Critical Review
Daniel B Chastain, Bryan P White, David A Cretella, et al.
Jac-Antimicrobial Resistance
|
March 27, 2026
In a bind: a quality improvement project for reducing fluoroquinolones drug-drug interactions with multivalent cations
Emily A Siegrist, Steven J Pan, Maria Alkozah, et al.
Open Forum Infectious Diseases
|
April 17, 2025
Rates of Acute Kidney Injury Utilizing Area Under the Concentration-Time Curve Versus Trough-Based Vancomycin Dosing Strategies in Patients With Obesity
Corey M Guidry, Emily A Siegrist, Stephen B Neely, et al.
Southern Medical Journal
|
February 3, 2018
Risk Factors for Failure in Complicated Intraabdominal Infections
Bryan P White, Jamie L Wagner, Katie E Barber, et al.
Page
of 5